Pennant Group (PNTG)

• Market cap: $1.03B
• 1 day: 0.30%
• 5 days: -4.04%
• 1 month: -9.66%
• 3 months: -6.03%
• 6 months: 31.57%
• Year to date: 110.70%
• 1 year: 123.45%
• 5 years: 14.24%
• 10 years: 98.28%
• Sector: Healthcare
• Industry: Health Services

About: Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Employees: 5,791

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

261% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $335K

100% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 6 (+3) [Q3]

100% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 19

53% more capital invested

Capital invested by funds: $607M [Q2] → $929M (+$321M) [Q3]

13% more funds holding

Funds holding: 151 [Q2] → 170 (+19) [Q3]

0.88% less ownership

Funds ownership: 87.12% [Q2] → 86.24% (-0.88%) [Q3]

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $37 24% upside
• Avg. target: $38 28% upside
• High target: $40 34% upside

4 analyst ratings

• positive: 3 75%
• neutral: 1 25%
• negative: 0 0%

Oppenheimer Michael Wiederhorn 44% 1-year accuracy 11 / 25 met price target	24% upside $37	Outperform Maintained	8 Nov 2024
RBC Capital Ben Hendrix 40% 1-year accuracy 23 / 57 met price target	27% upside $38	Outperform Maintained	23 Oct 2024
Stephens & Co. Scott Fidel 53% 1-year accuracy 9 / 17 met price target	34% upside $40	Overweight Reiterated	9 Oct 2024
Truist Securities David Macdonald 54% 1-year accuracy 26 / 48 met price target	27% upside $38	Hold Maintained	7 Oct 2024